Related Experiment Video

Updated: Jun 13, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Pseudocyst in pulmonary acute respiratory distress syndrome (ARDS)

Arun K Baranwal1, Sunit C Singhi, M Jayashree

  • 1Pediatric Emergency and Intensive Care Units, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Indian Journal of Pediatrics
|May 11, 2010
PubMed

Insights

Severe pediatric acute respiratory distress syndrome (ARDS) can lead to giant pulmonary pseudocysts. This case study highlights unusual lung abnormalities in a toddler recovering from severe ARDS.

Area of Science:

  • Pediatric Pulmonology
  • Critical Care Medicine
  • Radiology

Background:

  • Childhood acute respiratory distress syndrome (ARDS) is frequently caused by pneumonia.
  • Pulmonary pseudocysts are known complications in adults recovering from ARDS, typically affecting non-dependent lung areas.

Observation:

  • A 1.5-year-old boy survived severe ARDS.
  • The child developed pulmonary giant pseudocysts and other structural lung abnormalities.
  • These abnormalities were located in the dependent lung regions.

Findings:

  • This case presents the first reported instance of pulmonary abnormalities, specifically giant pseudocysts in dependent lung regions, in a toddler with extremely severe ARDS.
  • The findings challenge the typical presentation of pseudocysts in non-dependent areas seen in adults.

Implications:

  • This case expands the understanding of potential long-term pulmonary sequelae following severe pediatric ARDS.
  • Highlights the need for vigilant monitoring and advanced imaging in pediatric ARDS survivors.
  • Suggests potential differences in ARDS-related lung remodeling between pediatric and adult populations.

More Related Videos

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...